ArticleAdvances in therapy2024

Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure.

Tetiana A Berezina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.